Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1984-02-10
1985-04-02
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
2601125S, A61K 3700, C07C10352
Patent
active
045087113
ABSTRACT:
Novel cyclic pentapeptide somatostatin antagonist and method for increasing the release of growth hormone, insulin, and glucagon in mammals are described.
REFERENCES:
patent: 4146612 (1979-03-01), Veber
patent: 4310518 (1982-01-01), Freidinger et al.
patent: 4360516 (1982-11-01), Freidinger et al.
patent: 4374060 (1983-02-01), Nutt
Coy David H.
Murphy William A.
American Cyanamid Company
Noe Alphonse R.
Phillips Delbert R.
Tsevdos Estelle J.
LandOfFree
Cyclic pentapeptide displaying somatostatin antagonism and metho does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic pentapeptide displaying somatostatin antagonism and metho, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic pentapeptide displaying somatostatin antagonism and metho will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1090665